Residency · Residency · Internal Medicine

Infective Endocarditis: Duke Criteria and Management Dilemmas

Introduction

Infective endocarditis (IE) is a microbial infection of the heart valves or endocardial surface that carries high morbidity and mortality despite advances in diagnosis and treatment. The internist plays a critical role in clinical suspicion, appropriate blood culture collection, and coordinating multidisciplinary care. Delayed diagnosis remains a major contributor to poor outcomes.

Epidemiology and Risk Factors

Predisposing Conditions

• Degenerative valve disease has replaced rheumatic heart disease as the leading risk factor in developed countries
• Prosthetic heart valves: highest risk in the first year after implantation
• Injection drug use (IDU): predominantly right-sided (tricuspid) involvement; S. aureus is the most common pathogen
• Intracardiac devices (pacemakers, defibrillators), poor dentition, hemodialysis catheters
• Bicuspid aortic valve and mitral valve prolapse with regurgitation

Microbiology

• Staphylococcus aureus: most common cause overall; acute presentation; high mortality
• Viridans group streptococci: subacute presentation; associated with dental procedures
• Enterococcus faecalis: older adults, genitourinary tract source
• HACEK organisms: fastidious gram-negative rods; subacute course
• Culture-negative endocarditis (5-10%): prior antibiotics, Coxiella burnetii, Bartonella, fungi

Diagnosis

Modified Duke Criteria

• Definite IE: 2 major, or 1 major + 3 minor, or 5 minor criteria
• Possible IE: 1 major + 1 minor, or 3 minor criteria

Major Criteria

• Blood cultures: typical organism from 2 separate cultures, or persistently positive cultures
• Endocardial involvement: positive echocardiogram showing vegetation, abscess, or new valvular regurgitation

Minor Criteria

• Predisposing heart condition or injection drug use
• Fever >= 38.0 C
• Vascular phenomena: septic emboli, Janeway lesions, mycotic aneurysm, conjunctival hemorrhage
• Immunologic phenomena: Osler nodes, Roth spots, glomerulonephritis, positive rheumatoid factor
• Positive blood cultures not meeting major criteria

Blood Culture Technique

• Obtain at least 3 sets (6 bottles) from separate venipuncture sites before antibiotics
• Space collections over 1-2 hours if the patient is stable
• Do not draw cultures from indwelling lines if possible; peripheral cultures are preferred
• Hold antibiotics until cultures are drawn unless the patient is critically ill

Echocardiography

• Transthoracic echo (TTE): initial study; sensitivity 50-75% for native valve IE
• Transesophageal echo (TEE): sensitivity > 90%; indicated when TTE is negative but suspicion remains high, prosthetic valves, or suspected complications
• Repeat TEE in 5-7 days if initial study is negative and clinical suspicion persists

Management

Antibiotic Therapy

• Empiric therapy (native valve): vancomycin + ceftriaxone pending culture results
• MSSA native valve: nafcillin or cefazolin for 6 weeks
• MRSA: vancomycin or daptomycin for 6 weeks
• Viridans streptococci: ceftriaxone for 4 weeks; 2-week regimen with gentamicin if fully susceptible
• Enterococcal IE: ampicillin + ceftriaxone (preferred) or ampicillin + gentamicin for 6 weeks
• Prosthetic valve IE requires longer courses (>=6 weeks) and often surgical intervention

Surgical Indications

• Heart failure due to valvular dysfunction (most common indication)
• Uncontrolled infection despite appropriate antibiotics (persistent bacteremia > 7 days)
• Large vegetation (> 10 mm) with embolic events or high embolic risk
• Perivalvular abscess, fistula, or prosthetic valve dehiscence
• Fungal endocarditis or highly resistant organisms
• Early surgical consultation improves outcomes; do not delay referral

Complications

• Embolic stroke: occurs in 20-40% of left-sided IE; risk decreases after ART initiation
• Mycotic aneurysms: screen with CT angiography if neurologic symptoms
• Perivalvular abscess: suspect with persistent fever and new conduction abnormalities (PR prolongation)
• Splenic abscess: consider in persistent bacteremia; CT abdomen for evaluation
• Acute kidney injury: embolic infarction, immune complex glomerulonephritis, antibiotic nephrotoxicity

Key Clinical Pearls

• Always obtain blood cultures before antibiotics; at least 3 sets from separate sites
• TEE is required when TTE is negative but clinical suspicion is high, and in all prosthetic valve IE
• S. aureus bacteremia mandates echocardiography and a minimum 2-week IV course even without IE
• New conduction delay in a patient with IE suggests perivalvular abscess; obtain urgent TEE
• Multidisciplinary endocarditis team involvement improves mortality

References

1. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications. Circulation. 2015;132(15):1435-1486.
2. Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart J. 2015;36(44):3075-3128.
3. Holland TL, Baddour LM, Bayer AS, et al. Infective endocarditis. Nat Rev Dis Primers. 2016;2:16059.
4. Cahill TJ, Baddour LM, Habib G, et al. Challenges in infective endocarditis. J Am Coll Cardiol. 2017;69(3):325-344.

Read this lecture as Markdown